Table 1.
Jimma | Addis Ababa | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
R1 (Dec 20) | R2 (Jan 21) | R3 (Feb 21) | R4 (Aug 21) | R5 (Apr 22) | R1 (Jan 21) | R2 (Feb 21) | R3 (Apr 21) | R4 (Sep 21) | R5 (Mar 22) | |
Participants | 536 | 325 | 267 | 539 | 575 | 361 | 314 | 721 | 424 | 461 |
Age | 30 (19, 63) | 30 (19, 62) | 32 (19, 63) | 33 (20, 65) | 32 (19, 63) | 36 (21, 68) | 36 (22, 67) | 35 (21, 67) | 33 (19, 65) | 38 (20, 68) |
Sex | ||||||||||
Female | 260 (48.5%) | 166 (51.1%) | 136 (50.9%) | 331 (61.4%) | 317 (55.1%) | 279 (77.3%) | 236 (75.2%) | 360 (49.9%) | 209 (49.3%) | 162 (35.1%) |
Male | 276 (51.5%) | 159 (48.9%) | 131 (49.1%) | 207 (38.4%) | 258 (44.9%) | 79 (21.9%) | 70 (22.3%) | 109 (15.1%) | 71 (16.7%) | 299 (64.9%) |
Missing | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.2%) | 0 (0.0%) | 3 (0.8%) | 8 (2.5%) | 252 (35.0%) | 144 (34.0%) | 0 (0.0%) |
Anti-N positive | 139 (25.9%) | 114 (35.1%) | 107 (40.1%) | 313 (58.1%) | 543 (94.4%) | 165 (45.7%) | 150 (47.8%) | 234 (32.5%) | 286 (67.5%) | 458 (99.3%) |
Vaccinated | 0 (0.0%) | 0 (0.0%) | 1 (0.4%) | 47 (8.7%) | 195 (33.9%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 28 (6.6%) | 167 (36.2%) |
Age denoted as median and 90% quantiles, and sex in absolute and relative numbers. Round 1-3 (R1-R3) are the previous study1.